Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
GLP-1 Semaglutide Studied for weight management in appropriate patients
The primary trial intends to recruit approximately 1800 participants and will conclude in February 2026
Barney Graham Director of the David Satcher Global Health Equity Institute MorehouseSchool of Medicine Melissa Bishop-Murphy Senior Director, National Government Relations & Multicultural Affairs Co-Chair, Multicultural Health Equity Collective (formerly McoE)Pfizer Usha Ramakrishnan Chair, Global HealthEmory University, Rollins School of Public Health Rosalind Gregory-Bass Associate Professor Spelman College Gilberte Bastien Assistant Professor, Psychiatry & Behavioral Sciences Associate DirectorOffice of Global Health Equity, Morehouse School of Medicine Darlita Moy Clark Atlanta University Moderators: Kari Brossard Stoos, Anna Helova Limited funding, bureaucratic restraints, and increasing trends of risk aversions limit the effectiveness and advancement in global health operations and program implementations
International Journal of Molecular Sciences, 2018, 19 7
